BioCentury | Jul 16, 2020
Management Tracks

NextCure CMO Heller to resign; plus Vertex, Turning Point, Scholar Rock, C4, Vor and more

...hematopoietic stem cell cancer therapies (see “Vor Heads Into the Clinic” ). CNS disorders company Autobahn Therapeutics Inc....
...Sawka, BioCentury Staff Waters Corp. Vertex Pharmaceuticals Inc. Turning Point Therapeutics Inc. C4 Therapeutics Inc. Scholar Rock Holding Corp. Vor Biopharma Inc. Autobahn Therapeutics Inc. Cerevel...
Items per page:
1 - 1 of 1
BioCentury | Jul 16, 2020
Management Tracks

NextCure CMO Heller to resign; plus Vertex, Turning Point, Scholar Rock, C4, Vor and more

...hematopoietic stem cell cancer therapies (see “Vor Heads Into the Clinic” ). CNS disorders company Autobahn Therapeutics Inc....
...Sawka, BioCentury Staff Waters Corp. Vertex Pharmaceuticals Inc. Turning Point Therapeutics Inc. C4 Therapeutics Inc. Scholar Rock Holding Corp. Vor Biopharma Inc. Autobahn Therapeutics Inc. Cerevel...
Items per page:
1 - 1 of 1